Stock Photo - PRODUCTION - 10 December 2021, South Africa, Kapstadt: Researcher Bianca Arendse (l) and production engineer Dominique Vankerwel (r) work in Afrigen's R&D (research and development) lab. Afrigen Biologics and Vaccines, a biotechnology company in Cape Town, South Africa, is developing Africa's first proprietary corona vaccine. This is intended to mimic Moderna's highly effective mRNA preparation and thus reduce Africa's dependence on the pharmaceutical industry. (to dpa ""David against Goliath: Africa produces off-patent Corona vaccine"") Photo: Kristin Palitza/dpa. - Kapstadt/South Africa

Stock Photo: PRODUCTION - 10 December 2021, South Africa, Kapstadt: Researcher Bianca Arendse (l) and production engineer Dominique Vankerwel (r) work in Afrigen's R&D.

Searchable keywords

Choose multiple keywords